Joint effects of PON1 polymorphisms and vegetable intake on ischemic stroke: A family-based case control study

International Journal of Molecular Sciences

Volumn 18, Issue 12, 2017, Pages

  Juan, Juan ^a   Jiang, Xia ^b   Tang, Xun ^a   Wu, Yiqun ^a   Sun, Kexin ^a   Xiang, Xiao ^a   Tian, Yaohua ^a   Wu, Tao ^a   Sun, Qi ^b,c   Kraft, Peter ^b   Hu, Yonghua ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

Family based case control study; Gene diet interaction; Ischemic stroke; Ischemic stroke subtypes; PON1; Vegetable intake

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE; PON1 PROTEIN, HUMAN;

ADULT; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FOOD INTAKE; FRUIT; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PON1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; VEGETABLE; ADMINISTRATION AND DOSAGE; AGED; CARBOHYDRATE DIET; CEREBROVASCULAR ACCIDENT; DIET; GENETICS; PEDIGREE; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ARYLDIALKYLPHOSPHATASE; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; DIET; DIETARY CARBOHYDRATES; FEMALE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE; VEGETABLES;

EID: 85037649478     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18122652     Document Type: Article

References (57)

1. Benjamin, E.J.; Blaha, M.J.; Chiuve, S.E.; Cushman, M.; Das, S.R.; Deo, R.; de Ferranti, S.D.; Floyd, J.; Fornage, M.; Gillespie, C. et al. Heart disease and stroke statistics-2017 update: A report from the American heart association. Circulation 2017, 135, e146-e603.
2. Bonita, R. Epidemiology of stroke. Lancet 1992, 339, 342-344.
3. Lozano, R.; Naghavi, M.; Foreman, K.; Lim, S.; Shibuya, K.; Aboyans, V.; Abraham, J.; Adair, T.; Aggarwal, R.; Ahn, S.Y. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380, 2095-2128.
4. Feigin, V.L.; Forouzanfar, M.H.; Krishnamurthi, R.; Mensah, G.A.; Connor, M.; Bennett, D.A.; Moran, A.E.; Sacco, R.L.; Anderson, L.; Truelsen, T. et al. Global and regional burden of stroke during 1990-2010: Findings from the Global Burden of Disease Study 2010. Lancet 2014, 383, 245-254.
5. Hankey, G.J. Stroke. Lancet 2017, 389, 641-654.
6. Donnan, G.A.; Fisher, M.; Macleod, M.; Davis, S.M. Stroke. Lancet 2008, 371, 1612-1623.
7. Adams, H.P., Jr.; Bendixen, B.H.; Kappelle, L.J.; Biller, J.; Love, B.B.; Gordon, D.L.; Marsh, E.E. 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24, 35-41.
8. Furlong, C.E.; Suzuki, S.M.; Stevens, R.C.; Marsillach, J.; Richter, R.J.; Jarvik, G.P.; Checkoway, H.; Samii, A.; Costa, L.G.; Griffith, A. et al. Human PON1, a biomarker of risk of disease and exposure. Chem.-Biol. Interact. 2010, 187, 355-361.
9. Walsh, K.B.; Hart, K.; Roll, S.; Sperling, M.; Unruh, D.; Davidson, W.S.; Lindsell, C.J.; Adeoye, O. Apolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis. J. Stroke Cerebrovasc. Dis. 2016, 25, 1360-1365.
10. Chawhan, S.S.; Mogarekar, M.R.; Wagh, R.V.; Das, R.R.; Pramanik, S.S.; Sonune, S.M.; Chawhan, S.M. Relation of paraoxonase1, arylesterase and lipid profile in ischemic stroke patients. J. Clin. Diagn. Res. 2015, 9, Bc01-Bc03.
11. Michalak, S.; Kazmierski, R.; Hellmann, A.; Wysocka, E.; Kocialkowska-Adamczewska, D.; Wencel-Warot, A.; Nowinski, W.L. Serum paraoxonase/arylesterase activity affects outcome in ischemic stroke patients. Cerebrovasc. Dis. 2011, 32, 124-132.
12. Bhattacharyya, T.; Nicholls, S.J.; Topol, E.J.; Zhang, R.; Yang, X.; Schmitt, D.; Fu, X.; Shao, M.; Brennan, D.M.; Ellis, S.G. et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 2008, 299, 1265-1276.
13. Mackness, M.I.; Arrol, S.; Durrington, P.N. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 1991, 286, 152-154.
14. Mackness, B.; Durrington, P.N.; Mackness, M.I. Human serum paraoxonase. Gen. Pharmacol. 1998, 31, 329-336.
15. Humbert, R.; Adler, D.A.; Disteche, C.M.; Hassett, C.; Omiecinski, C.J.; Furlong, C.E. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 1993, 3, 73-76.
16. Davies, H.G.; Richter, R.J.; Keifer, M.; Broomfield, C.A.; Sowalla, J.; Furlong, C.E. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet. 1996, 14, 334-336.
17. Shenhar-Tsarfaty, S.; Waiskopf, N.; Ofek, K.; Shopin, L.; Usher, S.; Berliner, S.; Shapira, I.; Bornstein, N.M.; Ritov, Y.; Soreq, H. et al. Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities. Eur. J. Neurol. 2013, 20, 891-898.
18. Dahabreh, I.J.; Kitsios, G.D.; Kent, D.M.; Trikalinos, T.A. Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis. Genet. Med. 2010, 12, 606-615.
19. Liu, H.; Xia, P.; Liu, M.; Ji, X.M.; Sun, H.B.; Tao, L.; Mu, Q.W. PON gene polymorphisms and ischaemic stroke: A systematic review and meta analysis. Int. J. Stroke 2013, 8, 111-123.
20. Dauchet, L.; Amouyel, P.; Dallongeville, J. Fruit and vegetable consumption and risk of stroke: A meta-analysis of cohort studies. Neurology 2005, 65, 1193-1197.
21. Johnsen, S.P.; Overvad, K.; Stripp, C.; Tjonneland, A.; Husted, S.E.; Sorensen, H.T. Intake of fruit and vegetables and the risk of ischemic stroke in a cohort of Danish men and women. Am. J. Clin. Nutr. 2003, 78, 57-64.
22. Aune, D.; Giovannucci, E.; Boffetta, P.; Fadnes, L.T.; Keum, N.; Norat, T.; Greenwood, D.C.; Riboli, E.; Vatten, L.J.; Tonstad, S. Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies. Int. J. Epidemiol. 2017, 46, 1029-1056.
23. He, F.J.; Nowson, C.A.; MacGregor, G.A. Fruit and vegetable consumption and stroke: Meta-analysis of cohort studies. Lancet 2006, 367, 320-326.
24. Ranade, K.; Kirchgessner, T.G.; Iakoubova, O.A.; Devlin, J.J.; DelMonte, T.; Vishnupad, P.; Hui, L.; Tsuchihashi, Z.; Sacks, F.M.; Sabatine, M.S. et al. Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke. Stroke 2005, 36, 2346-2350.
25. Imai, Y.; Morita, H.; Kurihara, H.; Sugiyama, T.; Kato, N.; Ebihara, A.; Hamada, C.; Kurihara, Y.; Shindo, T.; Oh-hashi, Y. et al. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis 2000, 149, 435-442.
26. Mahrooz, A.; Gohari, G.; Hashemi, M.B.; Zargari, M.; Musavi, H.; Abedini, M.; Alizadeh, A. R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke. Mol. Biol. Rep. 2012, 39, 11177-11185.
27. Banerjee, I. Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: A meta-analysis. Eur. J. Epidemiol. 2010, 25, 449-458.
28. Xiao, Z.J.; Chen, J.; Sun, Y.; Zheng, Z.J. Lack of association between the paraoxonase 1 Q/R192 single nucleotide polymorphism and stroke in a Chinese cohort. Acta Neurol. Belg. 2009, 109, 205-209.
29. Zhang, G.; Li, W.; Li, Z.; Lv, H.; Ren, Y.; Ma, R.; Li, X.; Kang, X.; Shi, Y.; Sun, Y. Association between paraoxonase gene and stroke in the Han Chinese population. BMC Med. Genet. 2013, 14, 16.
30. Huang, Q.; Liu, Y.H.; Yang, Q.D.; Xiao, B.; Ge, L.; Zhang, N.; Xia, J.; Zhang, L.; Liu, Z.J. Human serum paraoxonase gene polymorphisms, Q192R and L55M, are not associated with the risk of cerebral infarction in Chinese Han population. Neurol. Res. 2006, 28, 549-554.
31. Mackness, B.; Mackness, M.I.; Arrol, S.; Turkie, W.; Durrington, P.N. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett. 1998, 423, 57-60.
32. Mackness, M.I.; Arrol, S.; Mackness, B.; Durrington, P.N. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation. Lancet 1997, 349, 851-852.
33. Mackness, M.I.; Mackness, B.; Durrington, P.N.; Connelly, P.W.; Hegele, R.A. Paraoxonase: Biochemistry, genetics and relationship to plasma lipoproteins. Curr. Opin. Lipidol. 1996, 7, 69-76.
34. Mueller, R.F.; Hornung, S.; Furlong, C.E.; Anderson, J.; Giblett, E.R.; Motulsky, A.G. Plasma paraoxonase polymorphism: A new enzyme assay, population, family, biochemical, and linkage studies. Am. J. Hum. Genet. 1983, 35, 393-408.
35. Kim, N.S.; Kang, K.; Cha, M.H.; Kang, B.J.; Moon, J.; Kang, B.K.; Yu, B.C.; Kim, Y.S.; Choi, S.M.; Bang, O.S. Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans. Biochem. Biophys. Res. Commun. 2007, 364, 157-162.
36. Mackness, M.I.; Arrol, S.; Abbott, C.; Durrington, P.N. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993, 104, 129-135.
37. Luu, H.N.; Kingah, P.L.; North, K.; Boerwinkle, E.; Volcik, K.A. Interaction of folate intake and the paraoxonase Q192R polymorphism with risk of incident coronary heart disease and ischemic stroke: The atherosclerosis risk in communities study. Ann. Epidemiol. 2011, 21, 815-823.
38. Lixandru, D.; Mohora, M.; Coman, A.; Stoian, I.; van Gils, C.; Aerts, P.; Manuel, Y.K.B. Diet and paraoxonase 1 enzymatic activity in diabetic foot patients from Romania and Belgium: Favorable association of high flavonoid dietary intake with arylesterase activity. Ann. Nutr. Metab. 2010, 56, 294-301.
39. Aviram, M.; Kaplan, M.; Rosenblat, M.; Fuhrman, B. Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development. Handb. Exp. Pharmacol. 2005, 170, 263-300.
40. Jarvik, G.P.; Tsai, N.T.; McKinstry, L.A.; Wani, R.; Brophy, V.H.; Richter, R.J.; Schellenberg, G.D.; Heagerty, P.J.; Hatsukami, T.S.; Furlong, C.E. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 1329-1333.
41. Durrington, P.N.; Mackness, B.; Mackness, M.I. The hunt for nutritional and pharmacological modulators of paraoxonase. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 1248-1250.
42. Lou-Bonafonte, J.M.; Gabas-Rivera, C.; Navarro, M.A.; Osada, J. PON1 and Mediterranean Diet. Nutrients 2015, 7, 4068-4092.
43. Daniels, J.A.; Mulligan, C.; McCance, D.; Woodside, J.V.; Patterson, C.; Young, I.S.; McEneny, J. A randomized controlled trial of increasing fruit and vegetable intake and how this influences the carotenoid concentration and activities of PON-1 and LCAT in HDL from subjects with type 2 diabetes. Cardiovasc. Diabetol. 2014, 13, 16.
44. Martini, D.; Del Bo, C.; Porrini, M.; Ciappellano, S.; Riso, P. Role of polyphenols and polyphenol-rich foods in the modulation of PON1 activity and expression. J. Nutr. Biochem. 2017, 48, 1-8.
45. Leikert, J.F.; Rathel, T.R.; Wohlfart, P.; Cheynier, V.; Vollmar, A.M.; Dirsch, V.M. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 2002, 106, 1614-1617.
46. Amakura, Y.; Tsutsumi, T.; Nakamura, M.; Kitagawa, H.; Fujino, J.; Sasaki, K.; Toyoda, M.; Yoshida, T.; Maitani, T. Activation of the aryl hydrocarbon receptor by some vegetable constituents determined using in vitro reporter gene assay. Biol. Pharm. Bull. 2003, 26, 532-539.
47. Gouedard, C.; Barouki, R.; Morel, Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol. Cell. Biol. 2004, 24, 5209-5222.
48. Ciolino, H.P.; Daschner, P.J.; Yeh, G.C. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J. 1999, 340 Pt 3, 715-722.
49. Laird, N.M.; Lange, C. Family-based designs in the age of large-scale gene-association studies. Nat. Rev. Genet. 2006, 7, 385-394.
50. Barrett, J.H.; Sheehan, N.A.; Cox, A.; Worthington, J.; Cannings, C.; Teare, M.D. Family based studies and genetic epidemiology: Theory and practice. Hum. Hered. 2007, 64, 146-148.
51. Tang, X.; Hu, Y.; Chen, D.; Zhan, S.; Zhang, Z.; Dou, H. the fangshan/family-based ischemic stroke study in China (FISSIC) protocol. BMC Med. Genet. 2007, 8, 60.
52. Meschia, J.F.; Brown, R.D., Jr.; Brott, T.G.; Chukwudelunzu, F.E.; Hardy, J.; Rich, S.S. The siblings with ischemic stroke study (SWISS) protocol. BMC Med. Genet. 2002, 3, 1.
53. Walker, A.E.; Robins, M.; Weinfeld, F.D. The national survey of stroke. Clinical findings. Stroke 1981, 12 (2 Pt 2 Suppl. S1), I13-I44.
54. Jones, W.J.; Williams, L.S.; Meschia, J.F. Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination. Stroke 2001, 32, 2232-2236.
55. Meschia, J.F.; Lojacono, M.A.; Miller, M.J.; Brott, T.G.; Atkinson, E.J.; O'Brien, P.C. Reliability of the questionnaire for verifying stroke-free status. Cerebrovasc. Dis. 2004, 17, 218-223.
56. Shu, X.O.; Yang, G.; Jin, F.; Liu, D.; Kushi, L.; Wen, W.; Gao, Y.T.; Zheng, W. Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women's Health Study. Eur. J. Clin. Nutr. 2004, 58, 17-23.
57. Hamilton, C.M.; Strader, L.C.; Pratt, J.G.; Maiese, D.; Hendershot, T.; Kwok, R.K.; Hammond, J.A.; Huggins, W.; Jackman, D.; Pan, H. et al. The Phen X Toolkit: Get the most from your measures. Am. J. Epidemiol. 2011, 174, 253-260.